We represented Mainsail Partners in its $30 million growth equity investment in Bio-Optronics. Bio-Optronics will use the capital and Mainsail’s support to accelerate product development, enhance customer service, and grow sales and marketing.

Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance.

Mainsail Partners is a San Francisco-based growth equity firm that invests in bootstrapped software companies.